Results 21 to 30 of about 1,338,841 (294)
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis [PDF]
, 2003 OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness.
Abrams, K. +6 more
core +2 more sources
Australian and New Zealand Journal of Public Health, 2015 Objectives: In New Zealand (NZ), place of death among decedents aged 65+ years has been reported as residential aged care (RAC, 38%), acute hospital (34%) or elsewhere (28%). However, lifetime risk of use of RAC (or nursing homes) is unknown.
Joanna B. Broad +5 more
doaj +1 more source
BMC Public Health, 2016 Background The DisMod II model is designed to estimate epidemiological parameters on diseases where measured data are incomplete and has been used to provide estimates of disease incidence for the Global Burden of Disease study.
Peter Scarborough +4 more
doaj +1 more source
Cost-effectiveness Of Sailcloth Selection For Different Classes, Types And Species Of Sailing Boats [PDF]
, 2017 Results over of theoretical analysis for the selection of corresponding basic material of sail clothes fabric for a different classes, types and views of sailing boats are given in the article.Sailing boats needs the proper of yachting equipment, that ...
Yeroshkina, S. (Svitlana)
core +2 more sources
Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in Uganda. [PDF]
In Sub-Saharan Africa, malaria remains a major cause of morbidity and mortality among children under 5, due to lack of access to prompt and appropriate diagnosis and treatment.
Clarke, Siân E +4 more
core +1 more source
Orphan drugs and the NHS: Should we value rarity [PDF]
, 2005 Cost effectiveness plays an important part in current decisions about the funding of health technologies. Drugs for rare disease (orphan drugs) are often expensive to produce and, by definition, will benefit only small numbers of patients.
Claxton, K., McCabe, C., Tsuchiya, A.
core +2 more sources
Delivering diabetes education through nurseled telecoaching : cost-effectiveness analysis [PDF]
, 2016 Background : People with diabetes have a high risk of developing micro-and macrovascular complications associated with diminished life expectancy and elevated treatment costs. Patient education programs can improve diabetes control in the short term, but
Aertgeerts, Bert +5 more
core +3 more sources
Assessing Hygiene Cost-Effectiveness [PDF]
, 2011 This paper introduces "hygiene effectiveness levels" as a tool for standardized analysis of costs and outcomes of hygiene promotion interventions.
Alana Potter +3 more
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Pediatric patients with extracranial solid tumors (ST) receiving chemotherapy are at an increased risk for Pneumocystis jirovecii pneumonia (PJP). However, evidence guiding prophylaxis practices in this population is limited. A PJP‐related fatality at our institution highlighted inconsistent prescribing approaches and concerns about
Kriti Kumar +8 more
wiley +1 more source
Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study. [PDF]
, 2020 Background:Rising healthcare costs motivate continued cost-reduction efforts. To help lower costs associated with open-angle glaucoma (OAG), a prevalent, progressive disease with substantial direct and indirect costs, clinicians need to understand the ...
Cioffi, George A +4 more
core